Enarodustat (JTZ-951) is a pharmaceutical compound used in the manufacturing of active pharmaceutical ingredients for anemia. It functions as an inhibitor of hypoxia-inducible factor-prolyl hydroxylase.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1262132-81-9
JTZ-951 hydrochloride
pharmaceutical raw material
Manidipine dihydrochloride
pharmaceutical raw material
Rifaximin-d6 (Major)
pharmaceutical raw material
Paromomycin sulfate
pharmaceutical raw material
Erythromycin ethylsuccinate
pharmaceutical raw material
2-[[7-oxo-5-(2-phenylethyl)-3H-[1,2,4]triazolo[1,5-a]pyridine-8-carbonyl]amino]acetic acid
FJYRBJKWDXVHHO-UHFFFAOYSA-N
C1=CC=C(C=C1)CCC2=CC(=O)C(=C3N2NC=N3)C(=O)NCC(=O)O